Search

Author/Creator Lai, Timothy Y Y

3. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Issue 10326 (19th February 2022)

Authors:
Heier, Jeffrey S; Khanani, Arshad M; Quezada Ruiz, Carlos; Basu, Karen; Ferrone, Philip J; Brittain, Christopher; Figueroa, Marta S; Lin, Hugh; Holz, Frank G; Patel, Vaibhavi; Lai, Timothy Y Y; Silverman, David; Regillo, Carl; Swaminathan, Balakumar; Viola, Francesco; Cheung, Chui Ming Gemmy; Won...
Journal:
Lancet
Issue:
Volume 399:Issue 10326(2022)
Page Start:
729
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study. Issue 4 (8th November 2021)

Authors:
Szeto, Simon KH; Hui, Vivian W. K.; Tang, Fang Yao; Yang, Dawei; Sun, Zi han; Mohamed, Shaheeda; Chan, Carmen K M; Lai, Timothy Y Y; Cheung, Carol
Journal:
British journal of ophthalmology
Issue:
Volume 107:Issue 4(2023)
Page Start:
525
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗